Noscapine HCl
Dapagliflozin Propanediol
Noscapine Base
Opium Tincture
Key Products of Parand Darou Pharmaceutical Company
About Us
Parand Darou Pharmaceutical Co.
Parand Darou is one of Iran’s leading knowledge-based pharmaceutical companies, focused on sustainable development, technological innovation, and international market expansion.
Established in 2006, the company specializes in the production of narcotic pharmaceutical products and is recognized as the second private company in Iran officially licensed by the Food and Drug Administration to manufacture these products.
In recent years, Parand Darou has achieved significant growth through exporting pharmaceutical products to international markets, expanding its presence in China, Russia, Chile, Kenya, India, El Salvador, Iraq, and Nigeria, obtaining GMP certification for its advanced production lines, developing API (Active Pharmaceutical Ingredient) production capabilities, and expanding its pharmaceutical product portfolio.
With a commitment to professional ethics, innovation, quality improvement, social responsibility, and environmental protection, Parand Darou aims to contribute to public health and improve quality of life.
Active Pharmaceutical Ingredient (API)
PAPAVER TO PHARMACEUTICAL
Pharmaceutical Intermediates
Papaverine Base
Papaverine Base is an opium-derived alkaloid and one of the most critical pharmaceutical intermediates manufactured by Parand Darou Co. It possesses potent antispasmodic properties and serves primarily as a key precursor in the synthesis of pharmaceutical products intended for the treatment of visceral and vascular spasms.
Clinical Applications
By acting directly...
Noscapine Base
Noscapine Base is a prominent natural poppy alkaloid and a key pharmaceutical intermediate manufactured by Parand Darou Co. It serves as a vital precursor in the synthesis of Noscapine Hydrochloride and various antitussive pharmaceutical formulations.
Pharmacological Significance
Unlike other opium derivatives, Noscapine is non-narcotic, non-sedating, and non-addictive. It exerts its antitussive...
Morphine Base
Morphine Base is the primary natural opioid alkaloid and one of the most strategic pharmaceutical intermediates manufactured by Parand Darou Co. It serves as a vital raw material and key precursor in the synthesis of various pharmaceutical salts, including Morphine Sulfate, Morphine Hydrochloride, and other semi-synthetic opioid analgesics and...
Noroxymorphone
Noroxymorphone is a strategic, semi-synthetic opioid intermediate manufactured by Parand Darou Co. This compound serves as a critical precursor and the fundamental building block in the synthesis of life-saving opioid antagonists, including Naloxone and Naltrexone, as well as the potent analgesic derivative Nalbuphine.
Pharmacological Significance
Characterized by a hydroxyl group at...
Parand Darou News
Parand Darou Awarded "National Exemplary Exporter" Title for the Second Time
According to the Public Relations department of Parand Darou...
Dr. Yahya Mirzaei Appointed as the New CEO of Parand Darou
In an official appointment, Mr. Behzad Mohammadi, CEO of...
Parand Darou Named National Exemplary Exporter of 2024: A Milestone in Pharmaceutical Innovation
On Sunday, October 20, 2024, coinciding with...
Finished Dosage Forms (FDFs)
Noscapine Syrup
Noscapine Syrup, marketed under the brand name pd NOSCA, is a specialized Finished Dosage Form (FDF) manufactured by Parand Darou Co. Containing 7 mg of Noscapine per 5 ml, this product is a potent non-narcotic antitussive. It acts centrally on the cough center in the medulla oblongata to effectively...
Methadone Syrup
Methadone Syrup is a key Finished Dosage Form (FDF) manufactured by Parand Darou Co. Formulated with a concentration of 25 mg per 5 ml (equivalent to 5 mg/ml), this product serves as a long-acting synthetic opioid agonist. It is extensively utilized in clinical protocols for Medication-Assisted Treatment (MAT) and...
Oxycodone FC Tablet
Oxycodone FC Tablet is a premium Finished Dosage Form (FDF) and a potent pure opioid agonist manufactured by Parand Darou Co. Engineered for clinical efficacy, Oxycodone acts primarily on central μ-opioid receptors to deliver robust analgesic relief. It is indicated for the management and relief of moderate-to-severe pain, particularly...
Pharma News
Olive Oil and Blood Pressure: Three Potential Pathways Supporting Heart Health
Extra virgin olive oil, due to its high content...
Regeneron’s Experimental Drug Combination May Help Preserve Muscle Mass During Weight Loss Treatment
Regeneron's Experimental Drug Combination May Help Preserve Muscle Mass During Weight Loss Treatment
According to new data scheduled to be...